| Rank | Title | Journal | Year | PubWeight™‹?› |
|---|---|---|---|---|
| 1 | Oxidative stress and ERK1/2 phosphorylation as predictors of outcome in hepatocellular carcinoma patients treated with sorafenib plus octreotide LAR. | Cell Death Dis | 2011 | 1.14 |
| 2 | Nanotech revolution for the anti-cancer drug delivery through blood-brain barrier. | Curr Cancer Drug Targets | 2012 | 0.91 |